1. Home
  2. SRRK vs OMF Comparison

SRRK vs OMF Comparison

Compare SRRK & OMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

N/A

Current Price

$56.23

Market Cap

6.8B

Sector

Health Care

ML Signal

N/A

Logo OneMain Holdings Inc.

OMF

OneMain Holdings Inc.

N/A

Current Price

$63.32

Market Cap

6.9B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
SRRK
OMF
Founded
2012
1920
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
6.9B
IPO Year
2018
2013

Fundamental Metrics

Financial Performance
Metric
SRRK
OMF
Price
$56.23
$63.32
Analyst Decision
Strong Buy
Buy
Analyst Count
13
12
Target Price
$56.17
$66.75
AVG Volume (30 Days)
981.1K
952.9K
Earning Date
05-07-2026
05-01-2026
Dividend Yield
N/A
7.25%
EPS Growth
N/A
54.72
EPS
N/A
1.93
Revenue
N/A
N/A
Revenue This Year
N/A
$66.43
Revenue Next Year
$534.24
$6.97
P/E Ratio
N/A
$31.97
Revenue Growth
N/A
N/A
52 Week Low
$27.07
$45.78
52 Week High
$58.49
$71.93

Technical Indicators

Market Signals
Indicator
SRRK
OMF
Relative Strength Index (RSI) 62.50 51.41
Support Level $45.81 $62.94
Resistance Level $58.49 $66.28
Average True Range (ATR) 2.38 1.35
MACD 0.63 -0.37
Stochastic Oscillator 93.21 33.55

Price Performance

Historical Comparison
SRRK
OMF

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

About OMF OneMain Holdings Inc.

OneMain Holdings Inc is a consumer finance company providing loan products to customers through its branch network and the internet. The company provides personal loan products; offers credit cards; offers optional credit insurance and others; offers a customer-focused financial wellness program, and acquisitions and dispositions of assets and businesses. It provides origination, underwriting, and servicing of personal loans to non-prime customers. The company operates in single reportable segment Consumer and Insurance which originates and services personal loans and auto finance loans, offer credit cards, and provide optional credit and non-credit insurance and other optional products through its branch and central operations, as well as digital platform.

Share on Social Networks: